Patients researching non surgical vaginal rejuvenation in Miami in 2026 almost always end up comparing two technologies: Femilift, the CO2 laser by Alma, and Morpheus8 V, the radiofrequency microneedling device by InMode. Both are well established, both work for the right candidates, and both produce real improvement. They also work in very different ways, and the right choice depends on what your specific tissue needs.
Most online comparisons read like marketing for whichever device the writer’s clinic uses. This guide is built around the actual differences in how each technology works, who benefits more from each, and how we sequence them in clinic. For broader context, see our pages on Femilift laser vaginal tightening and Morpheus8 V.
How Each Technology Works
Femilift: Fractional CO2 Laser
Femilift uses fractional CO2 laser energy delivered through a 360 degree vaginal probe. The laser creates tiny columns of controlled thermal injury in the surface tissue. The body responds by producing new collagen and elastin in that zone, plus new blood vessel growth.
CO2 laser works primarily in the surface layer (the epithelium) and just below it (the lamina propria). It does excellent work on tissue quality, hydration, and the protective vaginal environment. It is one of the most established devices for GSM and vaginal atrophy.
Morpheus8 V: Radiofrequency Microneedling
Morpheus8 V combines two technologies. Very fine needles create microscopic channels in the tissue. Radiofrequency energy is then delivered through those needles directly into the deeper tissue layer. The depth is adjustable, allowing the practitioner to target specific tissue depths based on the patient’s needs.
The RF energy heats the deeper tissue (the submucosa and deeper collagen layer) to a precise temperature, triggering structural remodeling at depths CO2 laser does not reach.
The single biggest difference: Femilift works the surface and shallow layers most effectively. Morpheus8 V reaches deeper. Same body part, different layers, different strengths.
When Femilift Is the Better Choice
Femilift tends to outperform Morpheus8 V when the primary issue is:
- Vaginal dryness and tissue thinning from menopause
- GSM (genitourinary syndrome of menopause) with surface and lamina propria changes
- Mild incontinence related to surface tissue changes
- Recurrent vaginal infections related to disrupted vaginal environment
- Patients who want a quick, comfortable in office treatment with minimal downtime
- Maintaining results after a comprehensive hormone and GSM plan
For a full explanation of how Femilift fits into a broader GSM plan, see our resource on vaginal atrophy and GSM treatment.
When Morpheus8 V Is the Better Choice
Morpheus8 V tends to outperform Femilift when the primary issue is:
- Deeper tissue laxity rather than just surface dryness
- Mild to moderate vaginal laxity after childbirth
- External laxity at the vulvar area (Morpheus8 V can address external tissue too)
- Mild stress incontinence with a structural component
- Patients with significant tissue thinning who need deeper remodeling
- Patients who want a single treatment platform for vaginal and external concerns
For postpartum patients specifically, the choice between Morpheus8 V and other options often depends on how much pelvic floor involvement there is. Our resource on pelvic floor after childbirth covers this decision in detail.
When Both Make Sense
In real clinical practice, the question is often not which to choose but how to sequence them. Some patients benefit most from a combined approach over the course of several months. A typical sequence might look like:
- Start with Femilift if surface dryness and GSM are dominant, alongside hormone optimization
- Add Morpheus8 V at 3 to 6 months if deeper laxity is still a concern
- Maintain with annual single sessions of whichever device produced the best individual result
Some patients also benefit from adding PRP intimate wellness (the O-Shot) to either or both protocols, particularly when sensitivity and blood flow are also concerns.
Side by Side Comparison
Mechanism
Femilift: Fractional CO2 laser energy in the surface and shallow tissue layers. Morpheus8 V: Radiofrequency microneedling delivering energy into deeper tissue layers.
Best For
Femilift: Dryness, atrophy, GSM, tissue quality. Morpheus8 V: Laxity, deeper tissue remodeling, combined internal and external treatment.
Sessions Needed
Femilift: Usually 3 sessions, 4 to 6 weeks apart. Morpheus8 V: Usually 3 sessions, 4 to 6 weeks apart. Same protocol structure for both.
Comfort During Treatment
Both are well tolerated with topical numbing. Most patients describe pressure and warmth rather than pain. Morpheus8 V can feel slightly more intense due to the needle component.
Recovery Time
Femilift: 3 to 5 days of mild discharge and tenderness. Morpheus8 V: 2 to 4 days of mild swelling and tenderness. Both require 7 days of pelvic rest before intercourse.
Cost in Miami in 2026
Femilift: Typically 800 to 1,800 dollars per session. Full 3 session package usually 2,200 to 4,500 dollars. Morpheus8 V: Typically 1,200 to 2,500 dollars per session. Full 3 session package usually 3,000 to 6,500 dollars.
Maintenance
Both typically require single touch up sessions every 12 to 24 months to maintain results.
External Treatment Capability
Femilift: Limited. Morpheus8 V: Yes, the platform can also address vulvar and external concerns with the same technology.
What Neither Can Do
Neither Femilift nor Morpheus8 V can replace surgery for significant structural laxity. Both are tissue remodeling treatments, not anatomy correction. Patients with major laxity, true prolapse, or who want a strong durable structural change usually need a surgical vaginoplasty. Our resource on vaginoplasty versus non surgical vaginal rejuvenation explains this side by side.
How Long Results Last
Initial improvement from either device starts at 4 to 6 weeks after the first session. Best results show up at 3 to 6 months after the final treatment, which is when the body has completed the bulk of new collagen and elastin production.
Most patients enjoy meaningful results for 18 to 36 months from a complete protocol. Aging continues, so does estrogen decline if untreated, which is why annual or every other year maintenance keeps results stable. For patients where pelvic floor weakness is also part of the picture, combining these tissue treatments with structured pelvic floor therapy produces stronger long term outcomes.
How We Decide in Our Practice
Every patient considering Femilift or Morpheus8 V at G-Nouva starts with a thorough exam and symptom assessment. The conversation covers what the patient is feeling, how long it has been going on, what they have already tried, what they want to feel different, and where they fall on the spectrum from surface dryness to deeper laxity.
For some patients, the answer is one device. For others, it is the other. For many, it is a sequenced combination. The goal is the best result, not the bigger package.
Frequently Asked Questions
Which is better, Femilift or Morpheus8 V?
Neither is universally better. They target different tissue layers and different problems. Femilift is excellent for dryness and atrophy. Morpheus8 V is excellent for laxity and deeper remodeling. The right choice depends on what you specifically need.
Can I do both Femilift and Morpheus8 V?
Yes, and many patients do over the course of several months. We typically sequence them rather than do both in the same session, giving the tissue time to respond to each before adding the next.
Which has more downtime?
Very similar. Both produce 2 to 5 days of mild tenderness, swelling, and discharge. Both require 7 days of pelvic rest. Most patients return to office work the next day.
Will either treatment fix bladder leaks?
For mild stress incontinence, yes, often. For moderate to severe incontinence, neither is enough alone. Both work better when combined with pelvic floor strengthening.
Can I do this if I had a hysterectomy?
Yes. Both treatments are appropriate after hysterectomy as long as the surgical site is fully healed and there are no other contraindications.
Do I need to be in menopause to benefit?
No. Both treatments can help younger women with postpartum laxity, mild incontinence, or tissue concerns. The benefits are not exclusive to menopausal patients.
Not sure whether Femilift or Morpheus8 V fits your tissue and goals? Book a focused vaginal rejuvenation consultation with Dr. Verdeza at G-Nouva in Doral, Miami. Call (786) 453-2785 or visit gnouva.com/contact.
About the Author
Dr. Carlos M. Verdeza is a board certified gynecologist and the founder of G-Nouva in Doral, Miami. He has fifteen plus years of experience in intimate wellness, cosmetic gynecology, hormone care, and menopause management. Full bio at gnouva.com/our-authors/dr-carlos-m-verdeza.
